2385P Long-term survival upon anti-PD-(L)1 monotherapy in metastatic urothelial cancer (mUC): A multicenter retrospective study von Stockem, C.F., Einerhand, S., Miras Rodriguez, I., Perez Valderrama, B., Vulsteke, C., De Meulenaere, A.M., Morales Barrera, R., Carles Galceran, J., Giannatempo, P., Rametta, A., Bottelli, A., Lefort, F., Bakaloudi, D.R., Talukder, R., Grivas, P., van der Heijden, M.S.

Volltext

112P Close cardiovascular monitoring during the early stages of treatment for patients receiving immune checkpoint inhibitors von Delombaerde, D.L., Vulsteke, C., Van de Veire, N., Vervloet, D., Moerman, V., van Calster, L., Croes, L., Gremonprez, F., De Meulenaere, A.M., Kraemer, X. Elzo, Wouters, K., Peeters, M., Prenen, H., De Sutter, J.

Volltext